Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neonatal lupus: basic research and clinical perspectives.

Jill P Buyon1, Robert M Clancy

  • 1Division of Rheumatology, Department of Medicine, New York University School of Medicine, New York, NY, USA. jill.buyon@nyumc.org

Rheumatic Diseases Clinics of North America
|June 1, 2005
PubMed
Summary

Neonatal lupus can cause severe fetal heart problems, primarily congenital heart block (CHB). Maternal anti-SSA/Ro and anti-SSB/La antibodies are linked to CHB, but fetal factors also play a role.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Children exposed to hydroxychloroquine in utero show no signs of retinal toxicity at age 5.

Lupus science & medicine·2026
Same author

Serum proteomic atlas reveals distinct molecular signatures of lupus nephritis activity, chronicity, and treatment response.

bioRxiv : the preprint server for biology·2026
Same author

Deep profiling of lupus nephritis kidneys reveals dynamic changes in myeloid cells associated with disease progression.

Annals of the rheumatic diseases·2026
Same author

Clinical, Histologic, and Serological Predictors of Renal Function Loss in Lupus Nephritis.

Arthritis care & research·2026
Same author

A population-scale atlas of blood and tissue in lupus nephritis.

bioRxiv : the preprint server for biology·2026
Same author

Transcription factor Etv3 controls the tolerogenic function of dendritic cells.

Science (New York, N.Y.)·2026

Area of Science:

  • Immunology
  • Cardiology
  • Neonatology

Background:

  • Neonatal lupus (NL) is a rare condition with significant fetal mortality and morbidity, particularly when the heart is affected.
  • Congenital heart block (CHB) is a primary cardiac manifestation of NL, occurring in structurally normal hearts.
  • Maternal autoantibodies, specifically anti-SSA/Ro and anti-SSB/La, are detected in over 85% of mothers with fetuses diagnosed with CHB.

Purpose of the Study:

  • To elucidate the pathogenic mechanisms underlying antibody-mediated cardiac injury in neonatal lupus.
  • To explore the spectrum of cardiac abnormalities in fetuses affected by neonatal lupus.
  • To identify optimal diagnostic approaches and potential prophylactic strategies for CHB in at-risk pregnancies.

Main Methods:

  • Review of in vivo and in vitro evidence detailing the pathological cascade.

Related Experiment Videos

  • Analysis of echocardiographic findings in fetuses with suspected CHB.
  • Examination of the role of maternal autoantibodies and fetal factors in disease development.

    • Main Results:

    • A proposed pathogenic cascade involves cardiocyte apoptosis, antigen translocation, autoantibody binding, and profibrotic factor secretion, leading to a myofibroblast-scarring phenotype.
    • The risk of a woman with candidate antibodies having a child with CHB is approximately 2%.
    • Cardiac abnormalities range from in utero diagnosed heart block to late-onset cardiomyopathy.

    Conclusions:

    • Maternal autoantibodies alone are insufficient to cause CHB; fetal factors are likely contributory.
    • Early detection of first-degree heart block in utero via echocardiography may be crucial for at-risk pregnancies.
    • Prophylactic therapies, such as intravenous immunoglobulin, require further investigation in larger clinical trials.